COVID-19 Vaccine Packaging And Delivery Devices Market Size, Share & Trends Analysis Report By Product (Syringes, Vials), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2025 - 2030
Europe Fill Finish Pharmaceutical Contract Manufacturing Market Growth & Trends
The Europe fill finish pharmaceutical contract manufacturing market size is expected to reach USD 9.54 billion by 2030, expanding at a CAGR of 8.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by factors such as the increasing demand for sterile injectable drugs, the rising prevalence of chronic diseases, and the growing focus on cost containment and efficiency by pharmaceutical companies. Additionally, advancements in technology and the increasing use of contract manufacturing by pharmaceutical companies are expected to drive market growth.
The Europe fill finish pharmaceutical contract manufacturing market is also characterized by a number of trends, such as the growing importance of regulatory compliance, the increasing use of single-use technology, and the rising adoption of advanced analytical and quality control systems. Additionally, there is a growing trend towards the use of contract manufacturing by small and mid-sized pharmaceutical companies, as well as by virtual biotech companies.
Germany dominated the market in 2024 owing to a strong base of biotechnology and pharmaceutical companies in the region. These companies are involved in drug discovery activities, which, in turn, led to the growth of the market in the region. The COVID-19 pandemic has had a significant impact, and one of the major impacts of the pandemic on the fill-finish contract manufacturing market in Europe has been an increased demand for COVID-19 vaccines and therapies. This has aided in increasing the demand for CMOs in the market since the fill-finish process requires advanced technology; thus, to reduce the cost, many Pharma and Biotech companies are more focused on outsourcing the fill-finish process, thereby boosting the overall market growth.
Europe Fill Finish Pharmaceutical Contract Manufacturing Market Report Highlights
- On the basis of product type, Vials dominated the market and accounted for a share of 53.4% in 2024 and Prefilled syringes are expected to grow at the fastest CAGR of 9.6% over the forecast period.
- Based on the Molecule type, the small molecule segment dominated the market in 2022 with the largest share of 67.3% in 2024 and is anticipated to show lucrative growth over the forecast period.
- Based on the End-use segment, the biopharmaceutical segment dominated the market and accounted for the largest revenue share of 35.9% in 2024. The increasing demand for biologics and biosimilars is driving the growth of the biopharmaceutical end-use segment. Due to the market for biologics and biosimilars experiencing rapid expansion, biopharmaceutical companies are the main consumers of fill-finish contract manufacturing services.
- The UK fill-finish pharmaceutical contract manufacturing market held the largest market share of 20.3% in 2024 in the Europe market and the fill-finish pharmaceutical contract manufacturing market in Germany is expected to grow at the fastest CAGR of 11.0% over the forecast period.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Regional scope
- 1.2.3. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
- Chapter 3. COVID-19 Vaccine Packaging And Delivery Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. High demand for efficient vaccine distribution
- 3.2.1.2. Government and international organization funding
- 3.2.1.3. Increased focus on vaccine accessibility
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Supply chain disruptions
- 3.2.2.2. Regulatory and compliance challenges
- 3.3. COVID-19 Vaccine Packaging And Delivery Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
- Chapter 4. COVID-19 Vaccine Packaging And Delivery Devices Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. COVID-19 Vaccine Packaging And Delivery Devices Market: Product Movement Analysis
- 4.3. COVID-19 Vaccine Packaging And Delivery Devices Market by Product Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Vials
- 4.5.1. Vials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.2. Glass
- 4.5.2.1. Glass Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3. Plastic
- 4.5.3.1. Plastic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Syringes
- 4.6.1. Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.2. Empty
- 4.6.2.1. Empty Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.3. Prefilled
- 4.6.3.1. Prefilled Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 5. COVID-19 Vaccine Packaging And Delivery Devices Market: Regional Estimates & Trend Analysis
- 5.1. Regional Dashboard
- 5.2. Regional COVID-19 Vaccine Packaging And Delivery Devices Market movement analysis
- 5.3. COVID-19 Vaccine Packaging And Delivery Devices Market: Regional Estimates & Trend Analysis by Technology & Type
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. North America
- 5.5.1. North America COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.2. U.S.
- 5.5.2.1. Key Country Dynamics
- 5.5.2.2. Competitive Scenario
- 5.5.2.3. Regulatory Framework
- 5.5.2.4. Reimbursement scenario
- 5.5.2.5. U.S. COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.3. Canada
- 5.5.3.1. Key Country Dynamics
- 5.5.3.2. Competitive Scenario
- 5.5.3.3. Regulatory Framework
- 5.5.3.4. Reimbursement scenario
- 5.5.3.5. Canada COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.4. Mexico
- 5.5.4.1. Key Country Dynamics
- 5.5.4.2. Competitive Scenario
- 5.5.4.3. Regulatory Framework
- 5.5.4.4. Reimbursement scenario
- 5.5.4.5. Mexico COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Europe
- 5.6.1. Europe COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.2. UK
- 5.6.2.1. Key Country Dynamics
- 5.6.2.2. Competitive Scenario
- 5.6.2.3. Regulatory Framework
- 5.6.2.4. Reimbursement scenario
- 5.6.2.5. UK COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.3. Germany
- 5.6.3.1. Key Country Dynamics
- 5.6.3.2. Competitive Scenario
- 5.6.3.3. Regulatory Framework
- 5.6.3.4. Reimbursement scenario
- 5.6.3.5. Germany COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.4. France
- 5.6.4.1. Key Country Dynamics
- 5.6.4.2. Competitive Scenario
- 5.6.4.3. Regulatory Framework
- 5.6.4.4. Reimbursement scenario
- 5.6.4.5. France COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.5. Italy
- 5.6.5.1. Key Country Dynamics
- 5.6.5.2. Competitive Scenario
- 5.6.5.3. Regulatory Framework
- 5.6.5.4. Reimbursement scenario
- 5.6.5.5. Italy COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.6. Spain
- 5.6.6.1. Key Country Dynamics
- 5.6.6.2. Competitive Scenario
- 5.6.6.3. Regulatory Framework
- 5.6.6.4. Reimbursement scenario
- 5.6.6.5. Spain COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.7. Denmark
- 5.6.7.1. Key Country Dynamics
- 5.6.7.2. Competitive Scenario
- 5.6.7.3. Regulatory Framework
- 5.6.7.4. Reimbursement scenario
- 5.6.7.5. Denmark COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.8. Sweden
- 5.6.8.1. Key Country Dynamics
- 5.6.8.2. Competitive Scenario
- 5.6.8.3. Regulatory Framework
- 5.6.8.4. Reimbursement scenario
- 5.6.8.5. Sweden COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.9. Norway
- 5.6.9.1. Key Country Dynamics
- 5.6.9.2. Competitive Scenario
- 5.6.9.3. Regulatory Framework
- 5.6.9.4. Reimbursement scenario
- 5.6.9.5. Norway COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Asia Pacific
- 5.7.1. Asia Pacific COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.2. Japan
- 5.7.2.1. Key Country Dynamics
- 5.7.2.2. Competitive Scenario
- 5.7.2.3. Regulatory Framework
- 5.7.2.4. Reimbursement scenario
- 5.7.2.5. Japan COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.3. China
- 5.7.3.1. Key Country Dynamics
- 5.7.3.2. Competitive Scenario
- 5.7.3.3. Regulatory Framework
- 5.7.3.4. Reimbursement scenario
- 5.7.3.5. China COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.4. India
- 5.7.4.1. Key Country Dynamics
- 5.7.4.2. Competitive Scenario
- 5.7.4.3. Regulatory Framework
- 5.7.4.4. Reimbursement scenario
- 5.7.4.5. India COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.5. South Korea
- 5.7.5.1. Key Country Dynamics
- 5.7.5.2. Competitive Scenario
- 5.7.5.3. Regulatory Framework
- 5.7.5.4. Reimbursement scenario
- 5.7.5.5. South Korea COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.6. Australia
- 5.7.6.1. Key Country Dynamics
- 5.7.6.2. Competitive Scenario
- 5.7.6.3. Regulatory Framework
- 5.7.6.4. Reimbursement scenario
- 5.7.6.5. Australia COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7.7. Thailand
- 5.7.7.1. Key Country Dynamics
- 5.7.7.2. Competitive Scenario
- 5.7.7.3. Regulatory Framework
- 5.7.7.4. Reimbursement scenario
- 5.7.7.5. Thailand COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8. Latin America
- 5.8.1. Latin America COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8.2. Brazil
- 5.8.2.1. Key Country Dynamics
- 5.8.2.2. Competitive Scenario
- 5.8.2.3. Regulatory Framework
- 5.8.2.4. Reimbursement scenario
- 5.8.2.5. Brazil COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8.3. Argentina
- 5.8.3.1. Key Country Dynamics
- 5.8.3.2. Competitive Scenario
- 5.8.3.3. Regulatory Framework
- 5.8.3.4. Reimbursement scenario
- 5.8.3.5. Argentina COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9. Middle East & Africa
- 5.9.1. Middle East & Africa COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9.2. South Africa
- 5.9.2.1. Key Country Dynamics
- 5.9.2.2. Competitive Scenario
- 5.9.2.3. Regulatory Framework
- 5.9.2.4. Reimbursement scenario
- 5.9.2.5. South Africa COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9.3. Saudi Arabia
- 5.9.3.1. Key Country Dynamics
- 5.9.3.2. Competitive Scenario
- 5.9.3.3. Regulatory Framework
- 5.9.3.4. Reimbursement scenario
- 5.9.3.5. Saudi Arabia COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9.4. UAE
- 5.9.4.1. Key Country Dynamics
- 5.9.4.2. Competitive Scenario
- 5.9.4.3. Regulatory Framework
- 5.9.4.4. Reimbursement scenario
- 5.9.4.5. UAE COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9.5. Kuwait
- 5.9.5.1. Key Country Dynamics
- 5.9.5.2. Competitive Scenario
- 5.9.5.3. Regulatory Framework
- 5.9.5.4. Reimbursement scenario
- 5.9.5.5. Kuwait COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 6. Competitive Landscape
- 6.1. Market Participant Categorization
- 6.2. Key Company Profiles
- 6.2.1. BD
- 6.2.1.1. Company overview
- 6.2.1.2. Financial performance
- 6.2.1.3. Product benchmarking
- 6.2.1.4. Strategic initiatives
- 6.2.2. B. Braun Melsungen AG
- 6.2.2.1. Company overview
- 6.2.2.2. Financial performance
- 6.2.2.3. Product benchmarking
- 6.2.2.4. Strategic initiatives
- 6.2.3. Hindustan Syringes & Medical Devices Ltd.
- 6.2.3.1. Company overview
- 6.2.3.2. Financial performance
- 6.2.3.3. Product benchmarking
- 6.2.3.4. Strategic initiatives
- 6.2.4. Terumo
- 6.2.4.1. Company overview
- 6.2.4.2. Financial performance
- 6.2.4.3. Product benchmarking
- 6.2.4.4. Strategic initiatives
- 6.2.5. NIPRO Medical Corporation
- 6.2.5.1. Company overview
- 6.2.5.2. Financial performance
- 6.2.5.3. Product benchmarking
- 6.2.5.4. Strategic initiatives
- 6.2.6. SCHOTT AG
- 6.2.6.1. Company overview
- 6.2.6.2. Financial performance
- 6.2.6.3. Product benchmarking
- 6.2.6.4. Strategic initiatives
- 6.2.7. Gerresheimer AG
- 6.2.7.1. Company overview
- 6.2.7.2. Financial performance
- 6.2.7.3. Product benchmarking
- 6.2.7.4. Strategic initiatives
- 6.2.8. Cardinal Health
- 6.2.8.1. Company overview
- 6.2.8.2. Financial performance
- 6.2.8.3. Product benchmarking
- 6.2.8.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook